DRUG DISCOVERY SYSTEMS CONSISTING

Brand Owner (click to sort) Address Description
LEADPROFILER AMNERSHAM PHARMACIA BIOTECH UK LIMITED Amersham Place Little Chalfont Buckinghamshire HP7 9NA drug discovery systems consisting of low light imager consisting of camera, camera chamber, focus tower, light-tight outer casing, and telecentric lens, filter wheels and lamps, and automated plate delivery device for detection of drugs; microtitre plates; and computer program for control of imager and review of assay all for scientific research use;reagents for use in radioactive and fluorometric assays used in scientific research;consulting services in the area of drug detection and assay review and analysis, and conducting assays for detection of drugs;
LEADSEEKER GE HEALTHCARE LIMITED UK AMERSHAM PLACE, LITTLE CHALFONT BUCKINGHAMSHIRE HP7 9NA United Kingdom Drug discovery systems consisting of low light imager consisting of camera, camera chamber, focus tower, light-tight outer casing, and telecentric lens, filter wheels and lamps, and automated plate delivery device for detection of drugs; microtitre plates; and computer program for control of imager and review of assay, all for scientific research use;LEAD SEEKER;[ Reagents for use in radioactive and fluorometric assays used in scientific research ];[ Consulting services in the area of drug detection and assay review and analysis, and conducting assays for detection of drugs ];
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. A crystal comprising LuxP is obtained, and a binding site for autoinducer-2 (AI-2) identified. The X-ray crystallographic data for LuxP and a LuxP-AI-2 complex is determined and used in a drug discovery method. Pharmaceutical compositions comprising ligands identified by such drug discovery methods are used to treat bacterial infections.